CLOUGH CAPITAL PARTNERS L P - INTRA CELLULAR THERAPIES INC ownership

INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 74 filers reported holding INTRA CELLULAR THERAPIES INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CLOUGH CAPITAL PARTNERS L P ownership history of INTRA CELLULAR THERAPIES INC
ValueSharesWeighting
Q1 2019$1,623,000
+6.0%
133,224
-0.9%
0.14%
-21.1%
Q4 2018$1,531,000
-85.9%
134,424
-73.2%
0.18%
-82.5%
Q3 2018$10,885,000
+8.0%
501,624
-12.1%
1.03%
+14.1%
Q2 2018$10,083,000
-4.1%
570,624
+14.2%
0.90%
-10.5%
Q1 2018$10,517,000
+3.8%
499,624
-28.6%
1.01%
+19.1%
Q4 2017$10,135,000
-2.5%
699,950
+6.3%
0.84%
+21.2%
Q3 2017$10,395,000
+122.1%
658,750
+74.8%
0.70%
+114.5%
Q2 2017$4,680,000
-68.0%
376,850
-58.1%
0.32%
-64.9%
Q1 2017$14,605,000
+176.8%
898,750
+157.0%
0.93%
+164.9%
Q4 2016$5,276,000
+101.5%
349,650
+103.5%
0.35%
+155.5%
Q3 2016$2,619,000
-70.1%
171,850
-23.8%
0.14%
-70.8%
Q2 2016$8,760,000
+57.5%
225,650
+12.8%
0.47%
+79.0%
Q1 2016$5,561,000
-50.4%
200,050
-4.1%
0.26%
-50.1%
Q4 2015$11,221,000
+0.4%
208,600
-25.2%
0.52%
+8.7%
Q3 2015$11,171,000
+57.6%
279,000
+25.8%
0.48%
+78.2%
Q2 2015$7,087,000
+31.9%
221,800
-1.4%
0.27%
+52.2%
Q1 2015$5,373,000225,0000.18%
Other shareholders
INTRA CELLULAR THERAPIES INC shareholders Q1 2015
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 175,000$9,115,75010.70%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 317,856$16,547,5835.57%
Deep Track Capital, LP 2,600,000$135,434,0005.23%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,369,849$71,355,4343.86%
SILVERARC CAPITAL MANAGEMENT, LLC 208,730$10,872,7463.30%
DCF Advisers, LLC 107,157$5,581,8083.04%
Bellevue Group AG 3,170,250$165,138,3232.66%
Vahanian & Associates Financial Planning Inc. 15,217$792,6542.55%
Iron Triangle Partners LP 330,549$17,218,2972.52%
TANG CAPITAL MANAGEMENT LLC 300,000$15,627,0002.20%
View complete list of INTRA CELLULAR THERAPIES INC shareholders